Jayamas Medica Industri
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfe… Read more
Jayamas Medica Industri (OMED) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, Jayamas Medica Industri (OMED) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp74.60 Billion) by net assets (Rp2.64 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jayamas Medica Industri - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Jayamas Medica Industri's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jayamas Medica Industri Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jayamas Medica Industri ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alembic Limited
NSE:ALEMBICLTD
|
0.020x |
|
Indústrias Romi S.A
SA:ROMI3
|
-0.005x |
|
Eolus Vind AB (publ)
ST:EOLU-B
|
0.793x |
|
FingerMotion Inc
NASDAQ:FNGR
|
-0.034x |
|
Sun Max Tech Ltd
TW:6591
|
0.040x |
|
Adagene Inc
NASDAQ:ADAG
|
-0.294x |
|
THN Corporation
KO:019180
|
0.100x |
|
ARTHA RESOURCES
F:16T
|
0.516x |
Annual Cash Flow Conversion Efficiency for Jayamas Medica Industri (2019–2024)
The table below shows the annual cash flow conversion efficiency of Jayamas Medica Industri from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp2.50 Trillion | Rp351.57 Billion | 0.141x | +135.43% |
| 2023-12-31 | Rp2.25 Trillion | Rp134.35 Billion | 0.060x | +33.69% |
| 2022-12-31 | Rp2.07 Trillion | Rp92.62 Billion | 0.045x | -88.96% |
| 2021-12-31 | Rp1.25 Trillion | Rp505.11 Billion | 0.406x | +38.31% |
| 2020-12-31 | Rp950.57 Billion | Rp278.73 Billion | 0.293x | +11.04% |
| 2019-12-31 | Rp661.59 Billion | Rp174.72 Billion | 0.264x | -- |